168 related articles for article (PubMed ID: 7854536)
1. Treatment of myasthenia gravis by immunoadsorption of plasma.
Grob D; Simpson D; Mitsumoto H; Hoch B; Mokhtarian F; Bender A; Greenberg M; Koo A; Nakayama S
Neurology; 1995 Feb; 45(2):338-44. PubMed ID: 7854536
[TBL] [Abstract][Full Text] [Related]
2. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption plasmapheresis for severe generalised myasthenia gravis.
Ichikawa M; Koh CS; Hata Y; Tohyama M; Tsuno T; Komiyama A
Arch Dis Child; 1993 Aug; 69(2):236-8. PubMed ID: 8215529
[TBL] [Abstract][Full Text] [Related]
4. Plasma exchange in myasthenia gravis: changes in serum complement and immunoglobulins.
Thorlacius S; Mollnes TE; Garred P; Aarli JA; Matre R; Tönder O; Halvorsen K
Acta Neurol Scand; 1988 Sep; 78(3):221-7. PubMed ID: 3227807
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption therapy and complement activation.
Pták J; Lochman J
Transfus Apher Sci; 2005 Jun; 32(3):263-7. PubMed ID: 15944112
[TBL] [Abstract][Full Text] [Related]
6. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
7. Immunoadsorption therapy for myasthenia gravis.
Shibuya N; Sato T; Osame M; Takegami T; Doi S; Kawanami S
J Neurol Neurosurg Psychiatry; 1994 May; 57(5):578-81. PubMed ID: 8201327
[TBL] [Abstract][Full Text] [Related]
8. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
Newsom-Davis J; Pinching AJ; Vincent A; Wilson SG
Neurology; 1978 Mar; 28(3):266-72. PubMed ID: 564482
[TBL] [Abstract][Full Text] [Related]
9. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
[TBL] [Abstract][Full Text] [Related]
10. Postoperative myasthenic crisis successfully treated with immunoadsorption therapy.
Ishizeki J; Nishikawa K; Kunimoto F; Goto F
J Anesth; 2005; 19(4):320-2. PubMed ID: 16261471
[TBL] [Abstract][Full Text] [Related]
11. Elimination of IgG subclasses of anti-acetylcholine receptor antibodies in myasthenic plasma by immunoadsorption to protein A.
Szpirt W; Somnier F; Nielsen FC; Rødgaard A
Life Support Syst; 1985; 3 Suppl 1():351-5. PubMed ID: 3916613
[No Abstract] [Full Text] [Related]
12. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
13. Removal of antiacetylcholine receptor antibodies by protein-A immunoadsorption in myasthenia gravis.
Berta E; Confalonieri P; Simoncini O; Bernardi G; Busnach G; Mantegazza R; Cornelio F; Antozzi C
Int J Artif Organs; 1994 Nov; 17(11):603-8. PubMed ID: 7744521
[TBL] [Abstract][Full Text] [Related]
14. Scale up and safety parameters of antigen specific immunoadsorption of human anti-acetylcholine receptor antibodies.
Lagoumintzis G; Zisimopoulou P; Trakas N; Grapsa E; Poulas K; Tzartos SJ
J Neuroimmunol; 2014 Feb; 267(1-2):1-6. PubMed ID: 24412396
[TBL] [Abstract][Full Text] [Related]
15. Plasma exchange with selective immunoadsorption of anti-acetylcholine receptor antibodies.
Somnier FE; Langvad E
J Neuroimmunol; 1989 Apr; 22(2):123-7. PubMed ID: 2647782
[TBL] [Abstract][Full Text] [Related]
16. Specific removal of anti-acetylcholine receptor antibodies in patients with myasthenia gravis.
Takamori M; Ide Y
Transfus Sci; 1996 Sep; 17(3):445-53. PubMed ID: 10163553
[TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
Yasuda M; Uzawa A; Ozawa Y; Kojima Y; Onishi Y; Akamine H; Kuwabara S
Scand J Immunol; 2022 Feb; 95(2):e13122. PubMed ID: 34796975
[TBL] [Abstract][Full Text] [Related]
18. Antigen-specific immunoadsorption of anti-acetylcholine receptor antibodies from sera of patients with myastenia gravis.
Sun C; Meng F; Li Y; Jin Q; Li H; Li F
Artif Cells Blood Substit Immobil Biotechnol; 2010 Apr; 38(2):99-102. PubMed ID: 20196680
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of a staphylococcal protein A immunoadsorption system in the treatment of myasthenia gravis patients.
Benny WB; Sutton DM; Oger J; Bril V; McAteer MJ; Rock G
Transfusion; 1999 Jul; 39(7):682-7. PubMed ID: 10413274
[TBL] [Abstract][Full Text] [Related]
20. Immunoadsorption in myasthenia gravis based on specific ligands mimicking the immunogenic sites of the acetylcholine receptor.
Takamori M; Maruta T
Ther Apher; 2001 Oct; 5(5):340-50. PubMed ID: 11778918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
